A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer.
Saved in:
| Title: | A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer. |
|---|---|
| Authors: | Wenham RM; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA. Electronic address: robert.wenham@moffitt.org., Buras AL; Salem Health, Gynecologic Oncology, Salem, OR, USA., Gordon SW; Sidney Kimmel Comprehensive Cancer Center, Division of Hematology and Oncology, Thomas Jefferson University, Philadelphia, PA, USA; Massey Comprehensive Cancer Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA, USA., Whiting J; Moffitt Cancer Center, Department of Biostatistics & Bioinformatics, Tampa, FL, USA., Fridley BL; Children's Mercy Kansas City, Division of Health Services and Outcomes Research, Kansas City, MO, USA., Dorman D; Clinical Trials Office, Moffitt Cancer Center, Tampa, FL, USA., Apte SM; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA., Chon HS; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA., Shahzad MM; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA., Randall LM; Massey Comprehensive Cancer Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA, USA; Inova Health System, Gynecologic Oncology Women's Service Line, Fairfax, VA, USA., Havrilesky LJ; Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute., Davidson BA; Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute., Secord AA; Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute. |
| Source: | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2026 Jun; Vol. 36 (6), pp. 102856. Date of Electronic Publication: 2025 Dec 13. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: BMJ Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
